skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: The Lancet remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

Hofman, Michael S ; Emmett, Louise ; Sandhu, Shahneen ; Iravani, Amir ; Joshua, Anthony M ; Goh, Jeffrey C ; Pattison, David A ; Tan, Thean Hsiang ; Kirkwood, Ian D ; Ng, Siobhan ; Francis, Roslyn J ; Gedye, Craig ; Rutherford, Natalie K ; Weickhardt, Andrew ; Scott, Andrew M ; Lee, Sze-Ting ; Kwan, Edmond M ; Azad, Arun A ; Ramdave, Shakher ; Redfern, Andrew D ; Macdonald, William ; Guminski, Alex ; Hsiao, Edward ; Chua, Wei ; Lin, Peter ; Zhang, Alison Y ; McJannett, Margaret M ; Stockler, Martin R ; Violet, John A ; Williams, Scott G ; Martin, Andrew J ; Davis, Ian D ; Azad, Arun A ; Chua, Wei ; Davis, Ian D ; Dhiantravan, Nattakorn ; Emmett, Louise ; Ford, Kate ; Hofman, Michael S ; Francis, Roslyn J ; Gedye, Craig ; Goh, Jeffrey C ; Guminski, Alex ; Hsiao, Edward ; Iravani, Amir ; Joshua, Anthony M ; Kirkwood, Ian D ; Langford, Ailsa ; Lawrence, Nicola ; Lee, Sze-Ting ; Lin, Peter ; Martin, Andrew J ; McDonald, William ; McJannett, Margaret M ; Ng, Siobhan ; Pattison, David A ; Ramdave, Shakher ; Rana, Nisha ; Redfern, Andrew D ; Rutherford, Natalie K ; Sandhu, Shahneen ; Scott, Andrew M ; Stockler, Martin R ; Subramaniam, Shalini ; Tan, Thean Hsiang ; Violet, John A ; Weickhardt, Andrew ; Williams, Scott G ; Yip, Sonia ; Zhang, Alison Y

The Lancet (British edition), 2021-02, Vol.397 (10276), p.797-804 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Galsky, Matthew D ; Arija, José Ángel Arranz ; Bamias, Aristotelis ; Davis, Ian D ; De Santis, Maria ; Kikuchi, Eiji ; Garcia-del-Muro, Xavier ; De Giorgi, Ugo ; Mencinger, Marina ; Izumi, Kouji ; Panni, Stefano ; Gumus, Mahmut ; Özgüroğlu, Mustafa ; Kalebasty, Arash Rezazadeh ; Park, Se Hoon ; Alekseev, Boris ; Schutz, Fabio A ; Li, Jian-Ri ; Ye, Dingwei ; Vogelzang, Nicholas J ; Bernhard, Sandrine ; Tayama, Darren ; Mariathasan, Sanjeev ; Mecke, Almut ; Thåström, AnnChristine ; Grande, Enrique

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1547-1557 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Targeted radioactive therapy for prostate cancer – Authors' reply
Targeted radioactive therapy for prostate cancer – Authors' reply
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted radioactive therapy for prostate cancer – Authors' reply

Hofman, Michael S ; Sandhu, Shahneen ; Francis, Roslyn J ; Davis, Ian D ; Emmett, Louise

The Lancet (British edition), 2021-08, Vol.398 (10299), p.488-488 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Triplet therapy for prostate cancer
Triplet therapy for prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Triplet therapy for prostate cancer

Davis, Ian D

The Lancet (British edition), 2022-04, Vol.399 (10336), p.1670-1671 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA
International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA
Material Type:
Artigo 		Adicionar ao Meu Espaço

International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA

Davis, D.L. ; Hoel, D. ; Fox, J. ; Lopez, A.

The Lancet (British edition), 1990-08, Vol.336 (8713), p.474-481 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate
Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate

Nicholaou, Theo ; Wong, Rachel ; Davis, Ian D

The Lancet (British edition), 2007-06, Vol.369 (9577), p.1923-1924 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Material Type:
Artigo 		Adicionar ao Meu Espaço

PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?

Rieckmann, K.H. ; Davis, D.R. ; Hutton, D.C.

The Lancet (British edition), 1989-11, Vol.334 (8673), p.1183-1184 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The study of health assessment and risk evaluation in Aboriginal peoples (SHARE-AP)
Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The study of health assessment and risk evaluation in Aboriginal peoples (SHARE-AP)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The study of health assessment and risk evaluation in Aboriginal peoples (SHARE-AP)

ANAND, Sonia S ; YUSUF, Salim ; JACOBS, Ruby ; DAVIS, A. Darlene ; QILONG YI ; GERSTEIN, Hertzel ; MONTAGUE, Patricia A ; LONN, Eva

The Lancet (British edition), 2001-10, Vol.358 (9288), p.1147-1153 [Periódico revisado por pares]

London: Lancet

Texto completo disponível

Citações Citado por
9
Plasmodium vivax resistance to chloroquine?
Plasmodium vivax resistance to chloroquine?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plasmodium vivax resistance to chloroquine?

RIECKMANN, K. H ; DAVIS, D.R ; HUTTON, D. C

The Lancet (British edition), 1989-11, Vol.2 (8673), p.1183-1184 [Periódico revisado por pares]

London: Lancet

Texto completo disponível

Citações Citado por
10
Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II

Tcheng, J E ; Lincoff, A M ; Sigmon, K N ; Lee, K L

The Lancet (British edition), 1997-05, Vol.349 (9063), p.1422-1428 [Periódico revisado por pares]

London: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.